TGF-β was reported to activate Akt directly or through upregulating hyaluronan synthase (HAS) expression, promoting CD44/EGFR expression and co-localization, and subsequently activating Akt in NSCLC cells [14, 51]. The gene discussed is CD44; the disease is non-small cell lung carcinoma.